K Number
K190810
Device Name
OPERA, OPERA eco
Manufacturer
Date Cleared
2019-08-30

(154 days)

Product Code
Regulation Number
884.5160
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The OPERA and OPERA eco are multiple-user, powered breast pumps intended to express and collect milk from the breasts of lactating women.

Device Description

The OPERA & OPERA eco are multiple-user, powered breast pumps intended to express and collect milk from the breasts of lactating women. The OPERA eco are provided non-sterile. Two models are available; Opera and Opera eco.

  • "OPERA" (pink color): powered by the adapter (AD/DC adapter, INPUT: AC 100 ~240V, . 50/60Hz, OUTPUT: DC14V, 2A) or by the internal battery (Rechargeable Lithium polymer battery, 11.1 V, 2200 mAh).
  • . "OPERA eco" (blue color): powered by the adapter (AD/DC adapter, INPUT: AC 100 ~240V, 50/60Hz, OUTPUT: DC14V, 2A).
    The OPERA & OPERA eco consists of a group of hardware and software components. The hardware component(s) consist of:
  • Opera or Opera eco pump body ●
  • Breast Shield Set (Breast shield, K-POP Diaphragm, Bottle Disk, Bottle Cover, Bottle ● Cap, Bottle, Nipple, White Valve, Diaphragm Cap, Air Tube Connector, Silicone Massager)
  • Adaptor
    The OPERA & OPERA eco provide the following user features:
    1. Two Modes
    • Massage Mode: 5 Levels
    • Expression Mode: 8 Levels
    1. Adjustment of vacuum level/cycles
    1. LCD Display, for user assistance/device status
      Principle and Theory of Operation:
      The Opera and Opera eco generate negative pressure on the breast and it moves diaphragm up and down to express and collect milk from the breasts of lactating women. To prevent backflow of breastmilk, Opera & Opera eco include a backflow protector on the top of breast shield. The inserted diaphragm blocks the upper side and bottom side of breast shield, which are the pathway of air and the breastmilk.
AI/ML Overview

This document is a 510(k) Premarket Notification from the FDA for a powered breast pump. It primarily focuses on demonstrating substantial equivalence to a predicate device, rather than providing details on a study proving a device meets specific clinical acceptance criteria.

Therefore, many of the requested details about acceptance criteria, study design, expert involvement, and ground truth cannot be fully provided from this document.

However, based on the information available, here's what can be extracted and inferred:

1. A table of acceptance criteria and the reported device performance

The document does not explicitly state clinical "acceptance criteria" in terms of performance metrics like accuracy, sensitivity, or specificity, as one might find for diagnostic devices. Instead, the acceptance criteria are demonstrated through compliance with established standards and performance tests confirming device functionality and safety.

Acceptance Criteria CategoryReported Device Performance (Summary from studies)
Electrical SafetyComplies with IEC 60601-1:2005/AM1:2012
Electromagnetic Compatibility (EMC)Complies with IEC 60601-1-2:2014
Home Healthcare Environment SafetyComplies with IEC 60601-1-11:2015
Software Validation (Moderate Concern Level)Designed and developed according to a software development process; verified and validated according to FDA guidance "The content of premarket submissions for software contained in medical devices, published on May 11, 2005".
BiocompatibilityAssessed per ISO 10993
Device Performance (Bench Tests)Demonstrated acceptable performance for: - Vacuum level settings - Speed settings - Backflow/cross-contamination protection - Battery operation (for OPERA model) - Use-life

2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)

This document details bench testing and compliance with standards, not clinical studies involving human subjects or patient data. Therefore, the concept of a "sample size for the test set" (in a clinical sense) and "data provenance" (like country of origin of clinical data, retrospective/prospective) is not applicable here. The testing involves validating the physical device and its software's performance against specifications and standards.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)

Not applicable. The ground truth for this type of device (a powered breast pump) is established by engineering specifications, international safety and performance standards (like IEC and ISO), and the device's ability to consistently meet these predefined technical parameters. There is no mention of human experts establishing a clinical "ground truth" for the device's function in this context.

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

Not applicable, as this is not a clinical study involving human assessment of outcomes that would require an adjudication method.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This is a medical device approval for a powered breast pump, not an AI-assisted diagnostic tool. No MRMC study or AI component is mentioned.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

Not applicable, as this device does not involve an algorithm with "standalone" performance in the context of AI or diagnostic interpretation. The device's operation regarding vacuum and speed settings can be considered "standalone" in its mechanical function, but this is not an algorithm in the sense typically asked about for AI/ML devices.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

The "ground truth" for the performance tests (bench tests) would be the established technical specifications and parameters for vacuum levels, cycle ranges, electrical safety, EMC, biocompatibility, and software functionality, as defined by relevant international standards (IEC, ISO) and the manufacturer's design requirements.

8. The sample size for the training set

Not applicable. This device does not use machine learning or AI that would require a "training set."

9. How the ground truth for the training set was established

Not applicable. No training set is used.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters 'FDA' in a blue square, followed by the words 'U.S. FOOD & DRUG ADMINISTRATION' in blue text.

August 30, 2019

Unimom Co. Sang-Hyun Hong President 110-19, Gajangsaneopseobuk-ro Osan-si, 18102 Gyeongg1-do KOREA

Re: K190810 Trade/Device Name: OPERA, OPERA eco Regulation Number: 21 CFR 884.5160 Regulation Name: Powered Breast Pump Regulatory Class: II

Product Code: HGX Dated: July 22, 2019 Received: July 29, 2019

Dear Sang-Hyun Hong:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you. however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal

{1}------------------------------------------------

statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Sharon M. Andrews Assistant Division Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of Gastrorenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known)

K190810

Device Name OPERA & OPERA eco

Indications for Use (Describe)

The OPERA and OPERA eco are multiple-user, powered breast pumps intended to express and collect milk from the breasts of lactating women.

Type of Use (Select one or both, as applicable)

| Prescription Use (Part 21 CFR 801 Subpart D)

X Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary – K190810 [As Required by 21 CFR 807.92]

Submitter's Information

Submitter's Name:Unimom Co.
Address:110-19, Gajangsaneopseobuk-ro, Osan-si,Gyeonggi-do, 18102, KOREA [Zip.18102]
Contact Person:Hong, Sang-Hyun
Telephone No.:+82-70-8798-5577
Fax No.:+82-31-372-6782
Email Address:infounimom@naver.com

Date Prepared

August 29, 2019

Trade Name, Regulation Name, Classification

Trade/Device NameOPERA & OPERA eco
Common NamePowered breast pump
Classification Number21 CFR 884. 5160
Classification NamePowered breast pump
Regulation ClassClass II
Product CodeHGX
Product Code NamePump, Breast, Powered

Identification of Predicate Device

The identified predicate devices within this submission are shown as follow;

510(k) Number:K180075
Applicant:Unimom Co.
Trade/Device Name:MINUET LCD, MINUET LCD eco
Classification Number:21 CFR 884. 5160
Classification Name:Powered breast pump
Regulation Class:Class II
Product Code:HGX

{4}------------------------------------------------

Product Code Name:

Pump, Breast, Powered

The predicate device has not been subject to a design-related recall.

Description of the Device

The OPERA & OPERA eco are multiple-user. powered breast pumps intended to express and collect milk from the breasts of lactating women. The OPERA eco are provided non-sterile. Two models are available; Opera and Opera eco.

  • "OPERA" (pink color): powered by the adapter (AD/DC adapter, INPUT: AC 100 ~240V, . 50/60Hz, OUTPUT: DC14V, 2A) or by the internal battery (Rechargeable Lithium polymer battery, 11.1 V, 2200 mAh).
  • . "OPERA eco" (blue color): powered by the adapter (AD/DC adapter, INPUT: AC 100 ~240V, 50/60Hz, OUTPUT: DC14V, 2A).

The OPERA & OPERA eco consists of a group of hardware and software components. The hardware component(s) consist of:

  • Opera or Opera eco pump body ●
  • Breast Shield Set (Breast shield, K-POP Diaphragm, Bottle Disk, Bottle Cover, Bottle ● Cap, Bottle, Nipple, White Valve, Diaphragm Cap, Air Tube Connector, Silicone Massager)
  • Adaptor

The OPERA & OPERA eco provide the following user features:

    1. Two Modes
    • Massage Mode: 5 Levels
    • Expression Mode: 8 Levels
    1. Adjustment of vacuum level/cycles
    1. LCD Display, for user assistance/device status

Principle and Theory of Operation:

The Opera and Opera eco generate negative pressure on the breast and it moves diaphragm up and down to express and collect milk from the breasts of lactating women. To prevent backflow of breastmilk, Opera & Opera eco include a backflow protector on the top of breast shield. The inserted diaphragm blocks the upper side and bottom side of breast shield, which are the pathway of air and the breastmilk.

Indications for Use

The OPERA & OPERA eco are multiple-user, powered breast pumps intended to express and collect milk from the breasts of lactating women.

{5}------------------------------------------------

Substantial Equivalence Comparison
subject and predicate devices.

Proposed DevicePredicate Device
Product NameOPERA, OPERA ecoMINUET LCD, MINUET LCD eco
510(k) NumberNot knownK180075
ManufacturerUnimom Co.Unimom Co.
Product CodeHGXHGX
Device ClassIIII
Indications for UseThe OPERA & OPERA eco are multiple- user, powered breast pumps intended to express and collect milk from the breasts of lactating women.The MINUET LCD and MINUET LCD eco are multiple-user, powered breast pumps intended to express and collect milk from the breasts of lactating women.
Intended use environmentHospital, Home environmentHospital, Home environment
Specifications
Power source (Adapter)AC/DC Adapter- Rated input: AC 100~240V, 50/60Hz- Rated output: DC14V, 2AAC/DC Adapter with Micro USB Cable- Rated input: AC 100~240V, 50/60Hz- Rated output: 5Vdc, 2A
Power source (Battery)Rechargeable Lithium Polymer Battery (Only for OPERA)Rechargeable Lithium Polymer Battery (Only for MINUET LCD)
Pump typeDiaphragmDiaphragm
Pump OptionsSingle or DoubleSingle or Double
Mode2 Modes(Massage Mode, Expression Mode)2 Modes(Massage Mode, Expression Mode)
Vacuum LevelsMassage Mode: 5 Levels Expression Mode: 8 LevelsMassage Mode: 7 Levels Expression Mode: 9 Levels
Vacuum Strength45 - 280 mmHg50 - 280 mmHg
Cycle RangeMassage Mode: 60 – 100 cycles/minExpression Mode: 26 - 42 cycles / minMassage Mode: 23 – 120 cycles/minExpression Mode: 13 - 60 cycles / min
User InterfaceSwitch control- Power, Vacuum / Cycle Up or Down- Mode switchLCD DisplaySwitch control- Power, Vacuum / Cycle Up or Down- Mode switchLCD Display
AccessoriesAir TubeBreast Shield Kit with back-flow protectorBottleBottle CoverNippleBottle CapBottle DiskBottle StandAdapterAir Tube ConnectorSilicone MassagerAir TubeBreast Shield Kit with back-flow protectorBottleBottle CoverNippleBottle CapBottle DiskBottle StandAdapterB-ConnectorMicro USB CableSilicone MassagerMicro USB Jack Cover
Backflow ProtectionYes(Milk is prevented from entering the tubing)Yes(Milk is prevented from entering the tubing)
Proposed DevicePredicate Device
Wipe with clean, damp cloth- Breast Shield Kit: Boiling waterWipe with clean, damp cloth- Breast Shield Kit: Boiling water

{6}------------------------------------------------

The indications for use statement of the subject device is unchanged from the predicate device; accordingly, the subject and predicate device have the same intended use. The subject and predicate device have similar technological characteristics, and the differences in technological characteristics do not raise different questions of safety or effectiveness.

Summary of Performance Testing

The following performance data were provided in support of the substantial equivalence determination:

  1. Electrical Safety, Electromagnetic Compatibility and Performance:

The OPERA & OPERA eco comply with the electrical safety and electromagnetic compatibility requirements established by the standards.

  • Electrical Basic Safety and Essential Performance requirements in accordance with IEC 60601-1:2005/AM1:2012
  • Electromagnetic Compatibility Testing in accordance with IEC 60601-1-2:2014 ●
  • Medical electrical equipment and medical electrical systems used in the home healthcare environment . in accordance with IEC 60601-1-11:2015

2) Software Validation

The OPERA & OPERA eco have a MODERATE level of concern. The software was designed and developed according to a software development process and was verified and validated. Software information is provided in accordance with FDA guidance:

  • "The content of premarket submissions for software contained in medical devices, published on May ● 11, 2005"

3) Biocompatibility

The OPERA & OPERA eco were assessed for biocompatibility per ISO 10993.

4) Performance testing

Bench tests using internal test protocols to demonstrate device performance, including vacuum level settings, speed settings, backflow/cross-contamination protection, battery operation, and use-life.

Conclusion

The performance testing demonstrate that the OPERA eco (K190810) are substantially equivalent to the predicate device, MINUET LCD, MINUET LCD eco (K180075).

§ 884.5160 Powered breast pump.

(a)
Identification. A powered breast pump in an electrically powered suction device used to express milk from the breast.(b)
Classification. Class II (performance standards).